Chicken Pox Info
Sunday, January 29, 2023
  • Home
  • Chickenpox
  • Monkeypox
  • Cowpox
  • Goatpox
  • Horsepox
  • Sheeppox
  • Squirrelpox
No Result
View All Result
  • Home
  • Chickenpox
  • Monkeypox
  • Cowpox
  • Goatpox
  • Horsepox
  • Sheeppox
  • Squirrelpox
No Result
View All Result
Chicken Pox Info
No Result
View All Result
Home Monkeypox

What Hospitals and Healthcare Facilities Need to Know

Chickenpox Info by Chickenpox Info
December 15, 2022
in Monkeypox
0
Male hands with Monkeypox rash. Patient with MonkeyPox viral disease. Close Up of Painful rash, red spots blisters on the skin. Human palm with Health problem. Banner, copy space. Allergy, dermatitis
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.


Male hands with Monkeypox rash. Patient with MonkeyPox viral disease. Close Up of Painful rash, red spots blisters on the skin. Human palm with Health problem. Banner, copy space. Allergy, dermatitis

With more than 25,000 cases of monkeypox worldwide and at least 10 reported deaths, the World Health Organization has declared this disease a global health emergency — the agency’s highest health alert. Meanwhile, President Joe Biden has deemed it a public health emergency. Below are facts about the monkeypox virus, followed by a Q&A with Laurie Sewell, president and CEO of Servicon, Southern California’s leading environmental services (EVS) provider.  

What is Monkeypox? 

Monkeypox is a rare disease caused by an infection from the monkeypox virus. The virus belongs to the orthopoxvirus genus, which also includes the virus that causes smallpox. It is called monkeypox because it was first detected in monkeys, but the virus transmits from person to person, and you do not need to be in close contact with animals to contract it. 

The first human case of monkeypox was recorded in 1970 in the Democratic Republic of the Congo (DRC). Cases outside Africa have been mainly tied to international travel or imported animals.  

Symptoms 

Symptoms of monkeypox in humans usually appear between seven and 14 days, although they can occur anytime within a five- and 21-day window. Symptoms include:
• Fever
• Headache
• Muscle aches
• Backache
• Swollen lymph nodes
• Chills
• Exhaustion 

Individuals Infected with monkeypox typically develop a rash that starts on the face and spreads to other parts of the body within three days of having a fever. The rash forms pimple-like lesions that can fill with pus and blister before falling off. Symptoms usually last between two and four weeks. 

Serious health complications that can arise from monkeypox and should not be taken lightly include:
• Severe scars on the face, arms, and legs
• Blindness
• Other infections
• Death, in rare cases (approximately 1 percent) 

Q & A With Servicon President and CEO Laurie Sewell: 

What challenges does monkeypox pose for healthcare facilities and hospitals?  

A. With COVID-19 still a threat — on top of lingering supply chain issues, inflation and staffing shortages — dealing with another global health emergency as contagious as monkeypox that is difficult to treat can overwhelm hospitals and other healthcare facilities physically, mentally and financially. It can also make overburdened healthcare workers more susceptible to contracting and spreading the virus. 

Do you think the available vaccine will make a difference to healthcare facilities are facing due to monkeypox?  

A. Servicon is a strong advocate for vaccines. We have a COVID-19 vaccination rate of over 90 percent among our team members, which we credit with keeping them and our clients and communities safer. Although the monkeypox vaccine is not as widely available as those for COVID, vaccination is the best way for at-risk groups to avoid severe illness from monkeypox or spreading it to others, especially unknowingly.  

How can healthcare facilities and hospitals be prepared if monkeypox continues to rise?  

A. Healthcare facilities can familiarize themselves with the in-depth monkeypox articles and updates, including specific infection-prevention strategies, on our website. Servicon’s Infection Prevention Task Force meets weekly to review the latest health and safety information from trusted government agencies and interpret what it means for our industry. We use various mediums, including social media, email and town hall meetings, to communicate necessary information to our clients and employees, usually in English and Spanish to ensure a wide reach and broad understanding.  

Given the number of trusted agencies and their different styles and platforms of communication, we recommend healthcare facilities work with a partner such as Servicon that knows how to navigate the various national, state, and local guidelines and regulations. Servicon has dedicated significant time and resources to this, especially throughout the pandemic, which has equipped us for handling monkeypox — and whatever comes next.  

What procedures are you employing to keep people safe? 

A. The infection-prevention procedures and safety protocols we implemented during the pandemic are very effective in preventing the spread of monkeypox and eliminating the virus. Our employees have received ongoing training throughout the pandemic and are fully prepared to combat monkeypox and keep themselves and our clients safe. 

Are there distinctions between preparing for monkeypox and COVID-19? 

A. The primary distinction between preparing to combat COVID and monkeypox is communicating the differences between the viruses. While less airborne than SARS-CoV-2 — the virus that causes COVID-19— monkeypox lives longer on surfaces, including linens such as clothes and bedding. So, while most cleaning and disinfecting protocols remain the same, the areas of concern differ. The differences need to be communicated clearly to people, especially healthcare workers. Further, Servicon uses PPE that protects our employees from the SARS-CoV-2 and monkeypox viruses.

What changes do you see in disinfecting procedures in the coming five years? 

A. We hope the pandemic will be far behind us within five years. However, the interconnectivity of the modern world, continued environmental degradation, and rise of the anti-vaccine/anti-science movement appears destined to lead to more global health emergencies. Hopefully, not to the level of the pandemic, but we should anticipate outbreaks like monkeypox will become more frequent.  

This means infection prevention is not going away but must be the baseline of operation within our industry. New technologies, such as UV light may become more scalable and common in the years ahead. Yet cleaning for health and focusing on infection prevention, including proper cleaning and responsible disinfection, is — and will remain — key. Companies will need to dedicate resources to infection prevention. The risks are not going away, and the time for healthcare facilities to prepare for future outbreaks is now. 

Laurie Sewell is president and CEO of Servicon, a leading hospital environmental services (EVS) provider headquartered in Southern California that operates with a mission: to elevate the industry and provide healthy environments for people to thrive. As a privately held, women-owned and operated company, Servicon works and lives by its vision of creating a better working future. To learn more about our EVS services and social and sustainability accomplishments, visit servicon.com or contact us. 




Industry News & Trends

Industry Training & Events

Advice from the Field

Insights & Updates




ShareTweetPin
Chickenpox Info

Chickenpox Info

Related Posts

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

by Chickenpox Info
January 27, 2023
0

Pharmacists should consider 2 critical safety issues when treating or vaccinating patients for monkeypox.First, it is vital to understand that...

Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.

Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.

by Chickenpox Info
January 27, 2023
0

Future Market Insights Global and Consulting Pvt. Ltd.Asia Pacific Monkeypox Treatment Market is projected to witness the fastest growth of...

Global Monkeypox Treatment Market to reach US$ 249 million

Global Monkeypox Treatment Market to reach US$ 249 million

by Chickenpox Info
January 27, 2023
0

DUBAI, United Arab Emirates, Jan. 26, 2023 (GLOBE NEWSWIRE) -- A recent Future Market Insights report on the monkeypox treatment...

Florida Health Orange County

DOH-Orange MPOX / Monkeypox Vaccination Update #12

by Chickenpox Info
January 26, 2023
0

Contact: Kent Donahue Kent.Donahue@flhealth.gov407-858-1418  ORLANDO, FL – The following update is provided to keep the community informed on the Florida Department...

Study: Clinical Testing of Pediatric Mpox Specimens: Unique Features and Challenges in a Low Prevalence Population. Image Credit: Dotted Yeti / Shutterstock

An evaluation of pediatric Mpox specimens

by Chickenpox Info
January 25, 2023
0

In a recent study posted to the medRxiv* preprint server, researchers in the United States performed the clinical evaluation of...

Next Post
Monkeypox vaccine here | Local News

Monkeypox vaccine here | Local News

Monkeypox Treatment Market Is Booming Worldwide 2022-2028 | SIGA Technologies Inc., Chimerix, Inc., Bavarian Nordic, Sanofi SA

Monkeypox Treatment Market Is Booming Worldwide 2022-2028 | SIGA Technologies Inc., Chimerix, Inc., Bavarian Nordic, Sanofi SA

RECOMMENDED

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

January 27, 2023
Global Monkeypox Treatment Market to reach US$ 249 million

Global Monkeypox Treatment Market to reach US$ 249 million

January 27, 2023

MOST VIEWED

  • Can you catch chickenpox twice? How contagious is virus and symptoms explained

    How long does chickenpox last? When do symptoms go away, how long is it contagious – and is there treatment

    0 shares
    Share 0 Tweet 0
  • What happened to monkeypox? Answers to your most pressing questions.

    0 shares
    Share 0 Tweet 0
  • TikTok craze of using calamine lotion as makeup causing chickenpox treatment shortages, pharmacy warns

    0 shares
    Share 0 Tweet 0
  • Research finds link between chickenpox and Alzheimer’s

    0 shares
    Share 0 Tweet 0
  • Can monkeypox spread through contaminated food?

    0 shares
    Share 0 Tweet 0

Chicken Pox Info

Welcome to Chicken Pox Info, where you will get all the latest news about all the different pox diseases, to stay up to date, and to protect yourself.

CATEGORY

  • Chickenpox
  • Cowpox
  • Goatpox
  • Horsepox
  • Monkeypox
  • Sheeppox
  • Squirrelpox

Site Links

  • Home
  • About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions

Latest News

  • Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox
  • Global Monkeypox Treatment Market to reach US$ 249 million
  • Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.

Copyright © 2022 Chickenpoxinfo.com | All Rights Reserved.

No Result
View All Result
  • Home
  • Chickenpox
  • Monkeypox
  • Cowpox
  • Goatpox
  • Horsepox
  • Sheeppox
  • Squirrelpox

Copyright © 2022 Chickenpoxinfo.com | All Rights Reserved.

What Are Cookies
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT